Literature DB >> 9798873

Percutaneous removal of benign mammographic lesions: comparison of automated large-core and directional vacuum-assisted stereotactic biopsy techniques.

R J Jackman1, F A Marzoni, K W Nowels.   

Abstract

OBJECTIVE: The purpose of our study was to evaluate how often histologically benign lesions were completely removed as shown by the initial mammogram after biopsy. We compared three percutaneous biopsy techniques.
MATERIALS AND METHODS: Retrospective review was performed on 1206 consecutive impalpable breast lesions having percutaneous stereotactic biopsies done on a prone biopsy table using 14-gauge automated large-core needles (n = 721); 14-gauge directional vacuum-assisted probes (n = 192); and 11-gauge directional vacuum-assisted probes (n = 293). Lesions that were histologically benign and that did not have subsequent surgical excision had mammographic follow-up. The 667 initial mammograms after biopsy (advised to be done at 6 or 12 months and accomplished at 1-53 months [median, 7 months] after biopsy) were reviewed to see if the lesions were no longer apparent.
RESULTS: The lesion was absent in 9% (40/422) of lesions for which 14-gauge large-core biopsy was used, 22% (21/95) of lesions for which 14-gauge vacuum-assisted biopsy was used, and 64% (96/150) of lesions for which 11-gauge vacuum-assisted biopsy was used (p < .0001). No mammographic pseudolesions were created by the biopsy. No clinically significant complications occurred.
CONCLUSION: The lesion was more often completely removed with directional vacuum-assisted biopsy than with automated large-core biopsy and more often completely removed with 11-gauge probes than with 14-gauge probes.

Mesh:

Year:  1998        PMID: 9798873     DOI: 10.2214/ajr.171.5.9798873

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  8 in total

1.  A review of needle core biopsy diagnosed radial scars in the Welsh Breast Screening Programme.

Authors:  G Osborn; F Wilton; G Stevens; E Vaughan-Williams; K Gower-Thomas
Journal:  Ann R Coll Surg Engl       Date:  2010-11-12       Impact factor: 1.891

2.  Values of pathological analysis of lost tissue fragments in the vacuum canister during a vacuum-assisted stereotactic biopsy of the breast.

Authors:  M El Khoury; B Mesurolle; A Omeroglu; A Aldis; E Kao
Journal:  Br J Radiol       Date:  2013-03-21       Impact factor: 3.039

3.  Borderline breast lesions: comparison of malignancy underestimation rates with 14-gauge core needle biopsy versus 11-gauge vacuum-assisted device.

Authors:  Viviana Londero; Chiara Zuiani; Anna Linda; Luisa Battigelli; Giovanni Brondani; Massimo Bazzocchi
Journal:  Eur Radiol       Date:  2011-01-12       Impact factor: 5.315

4.  The current role of vacuum assisted breast biopsy system in breast disease.

Authors:  Hai-Lin Park; Lee Su Kim
Journal:  J Breast Cancer       Date:  2011-03-31       Impact factor: 3.588

5.  A comparison of diagnostic performance of vacuum-assisted biopsy and core needle biopsy for breast microcalcification: a systematic review and meta-analysis.

Authors:  Xu Chen Huang; Xu Hua Hu; Xiao Ran Wang; Chao Xi Zhou; Fei Fei Wang; Shan Yang; Gui Ying Wang
Journal:  Ir J Med Sci       Date:  2018-03-16       Impact factor: 1.568

6.  High Residual Tumor Rate for Early Breast Cancer Patients Receiving Vacuum-assisted Breast Biopsy.

Authors:  Xiao-Fang He; Feng Ye; Jia-Huai Wen; Shuai-Jie Li; Xiao-Jia Huang; Xiang-Sheng Xiao; Xiao-Ming Xie
Journal:  J Cancer       Date:  2017-02-11       Impact factor: 4.207

7.  Ultrasound-guided vacuum-assisted breast biopsy with a small-caliber device: A multicenter consecutive study of 162 biopsied lesions.

Authors:  Christophe Tourasse; Elina Khasanova; Philippe Sebag; Jean Paul Beregi
Journal:  Tumori       Date:  2018-07-09       Impact factor: 2.098

8.  Stereotactic vacuum biopsy of calcifications with a handheld portable biopsy system: a validation study.

Authors:  P Taourel; D Hoa; C Chaveron; C Balu-Maestro; D Gros; M C Baranzelli; F Ettore; M F Bretz-Grenier; P Roger
Journal:  Eur Radiol       Date:  2008-03-20       Impact factor: 7.034

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.